Oncology Innovations: Novel Approaches to Immunotherapy in mESCC

Target Audience
This activity is designed to meet the educational needs of medical oncologists, gastroenterologists, and other HCPs who treat patients with esophageal carcinoma.

Program Overview
This activity will cover the advances in the therapeutic paradigm for patients with esophageal carcinoma in a digital, interactive infographic format.

Learning Objectives
Upon completion of this activity, participants should be better able to:

Develop treatment strategies for patients with metastatic esophageal squamous cell carcinoma who do not respond to chemotherapy and who are not candidates for surgery.  
Demonstrate the appropriate role of biomarker testing in developing treatment plans for patients with esophageal squamous cell carcinoma.  
Recall relevant clinical trial data for immunotherapeutic agents used in treating patients with advanced esophageal squamous cell carcinoma. 
Analyze treatment options based on potential adverse events for patients with esophageal squamous cell carcinoma.